GMAB:NASDAQ
Genmab A/S - ADR
US$ ५०.९७
arrow_downward
-१.९१%(-०.९९) 1D
US$ ५०.९४
arrow_downward
-०.०५% (-०.०२८)bedtimeAfter hours
Closed: नोभेम्बर १८, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
US$ ५१.६०
High
US$ ५२.२६
Low
US$ ५०.८९
Mkt. cap
३१.६३ अरब
Avg. vol.
५४.७६ लाख
Volume
०.००
P/E ratio
४३.४१
52-wk high
US$ ५९.९७
52-wk low
US$ २३.६२
EPS
US$ १.१७
Beta
०.७३
Shares outstanding
६२.५७ करोड
No. of employees
३ हजार
Open
US$ ५१.६०
High
US$ ५२.२६
Low
US$ ५०.८९
Mkt. cap
३१.६३ अरब
Avg. vol.
५४.७६ लाख
Volume
०.००
P/E ratio
४३.४१
52-wk high
US$ ५९.९७
52-wk low
US$ २३.६२
EPS
US$ १.१७
Beta
०.७३
Shares outstanding
६२.५७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Yahoo Finance
·
१३ घण्टा पहिले
Grant of Restricted Stock Units and Warrants to Employees in Genmab
kalkine.ca
·
२ दिन पहिले
GMAB: Royalties and Oncology Portfolio Advance as Acquisition Costs Weigh on Earnings
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees३.२४ हजार
Founded१९९९
Headquarters-
SectorHealth Care
Industry-
Websitegenmab.com